
Health Financing at Risk: Geopolitics, Markets, and Policy at a Turning Point
Sertig 2 · Mountain Plaza Hotel
Global health financing is entering a period of heightened uncertainty. Geopolitical fragmentation, evolving trade and pricing policies, fiscal constraints, and shifting public-sector priorities are placing increasing strain on health systems worldwide. These pressures are particularly acute for countries striving to sustain progress toward universal health coverage amid rising costs and growing demand. This session will convene senior decision-makers to assess how geopolitical forces are reshaping health financing markets and policy choices, and to examine the role of innovative financing mechanisms, public-private collaboration, and policy alignment in navigating this turning point.
Speakers (6)

Andrea Feigl
Senior Director, Deloitte

Dr. Asif Dhar
Global Consulting Services (GCS) Growth Leader, Deloitte

Christophe Weber
President, CEO and Representative Director, Takeda Pharmaceuticals

Stefan Weber
VP and Head of Global Policy, Advocacy and Health Equity, AstraZeneca

Dan Vahdat
CEO, Huma Therapeutics

Gargee Ghosh
President of Global Policy and Advocacy, Gates Foundation